Boateng Joshua S, Matthews Kerr H, Stevens Howard N E, Eccleston Gillian M
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, John Arbuthnott Building, 27 Taylor Street, Glasgow G4 0NR, UK.
J Pharm Sci. 2008 Aug;97(8):2892-923. doi: 10.1002/jps.21210.
The variety of wound types has resulted in a wide range of wound dressings with new products frequently introduced to target different aspects of the wound healing process. The ideal dressing should achieve rapid healing at reasonable cost with minimal inconvenience to the patient. This article offers a review of the common wound management dressings and emerging technologies for achieving improved wound healing. It also reviews many of the dressings and novel polymers used for the delivery of drugs to acute, chronic and other types of wound. These include hydrocolloids, alginates, hydrogels, polyurethane, collagen, chitosan, pectin and hyaluronic acid. There is also a brief section on the use of biological polymers as tissue engineered scaffolds and skin grafts. Pharmacological agents such as antibiotics, vitamins, minerals, growth factors and other wound healing accelerators that take active part in the healing process are discussed. Direct delivery of these agents to the wound site is desirable, particularly when systemic delivery could cause organ damage due to toxicological concerns associated with the preferred agents. This review concerns the requirement for formulations with improved properties for effective and accurate delivery of the required therapeutic agents. General formulation approaches towards achieving optimum physical properties and controlled delivery characteristics for an active wound healing dosage form are also considered briefly.
伤口类型的多样性导致了各种各样的伤口敷料,并且经常有新产品推出,以针对伤口愈合过程的不同方面。理想的敷料应以合理的成本实现快速愈合,同时给患者带来最小的不便。本文综述了常见的伤口处理敷料以及用于改善伤口愈合的新兴技术。它还回顾了许多用于向急性、慢性和其他类型伤口递送药物的敷料和新型聚合物。这些包括水胶体、藻酸盐、水凝胶、聚氨酯、胶原蛋白、壳聚糖、果胶和透明质酸。文中还有一个简短的部分介绍了生物聚合物作为组织工程支架和皮肤移植物的用途。讨论了抗生素、维生素、矿物质、生长因子和其他参与愈合过程的伤口愈合促进剂等药理剂。将这些药剂直接递送至伤口部位是可取的,特别是当全身给药由于与首选药剂相关的毒理学问题而可能导致器官损伤时。本综述关注具有改进特性的制剂对于有效和准确递送所需治疗剂的要求。还简要考虑了实现活性伤口愈合剂型的最佳物理性质和控释特性的一般制剂方法。